Perrigo to Attend Morgan Stanley Global Consumer & Retail Conference
abrdn Japan Equity Fund (NYSE:JEQ) announced a $0.6944 per-share cash distribution payable October 7, 2025, with record and ex-date of September 29, 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
abrdn Japan Equity Fund (NYSE:JEQ) announced a $0.6944 per-share cash distribution payable October 7, 2025, with record and ex-date of September 29, 2025.
The distribution is estimated to consist of $0.2752 (40%) net investment income and $0.4192 (60%) return of capital. Fiscal year-to-date distributions total $0.9244 (with $0.5052 from net investment income and $0.4192 return of capital).
The distribution is final before JEQ's approved reorganization into abrdn Global Infrastructure Income Fund (NYSE:ASGI); shareholders of JEQ at market close October 10, 2025 will receive newly issued ASGI shares and be deemed ASGI shareholders at market open October 13, 2025.
Five-year NAV return is 5.49% and current fiscal-period annualized distribution rate on NAV is 2.79%.
Positive
- $0.6944 per-share cash distribution payable Oct 7, 2025
- Reorganization into ASGI with share exchange effective Oct 10–13, 2025
- Fiscal year-to-date distributions of $0.9244 per share
- Five-year NAV total return of 5.49%
Negative
- Current distribution is estimated 60% return of capital
- Distribution payment may reduce net assets and raise expense ratio
Details
News Market Reaction – PRGO
On Nov 18, the day this news came out, PRGO closed 1.25% below the previous close.
Data tracked by StockTitan Argus for the Nov 18 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
About Perrigo
Perrigo Company plc is a leading pure-play consumer health company with over a century of experience in providing high-quality health and wellness solutions to consumers primarily in
Perrigo's unique business model leverages its complementary businesses, where cash-generative store brand private label offerings fuel investments for leading brands, including Opill®, Mederma®, Compeed®, EllaOne®, and Jungle Formula®.
For more information, visit www.perrigo.com.
Forward-Looking Statements
This press release includes, and the matters discussed at the Morgan Stanley Global Consumer & Retail Conference will include certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements involve known and unknown risks, uncertainties and other factors—many of which are beyond the Company's control—that may cause the actual results, performance or achievements of the Company to be materially different from its current expectations, assumptions, estimates and projections. Interested persons are urged to consult the Company's filings with the United States Securities and Exchange Commission, available at https://investor.perrigo.com/sec-filings, for a discussion of the Company's business and financial condition and certain material trends, risks, uncertainties and other factors relating thereto, including those discussed under "Risk Factors" in the Company's Form 10-K for the year ended December 31, 2024.
Perrigo Contact
Bradley Joseph, Vice President, Global Investor Relations, (269) 686-3373, E-mail: bradley.joseph@perrigo.com
Nicholas Gallagher, Associate Director, Global Investor Relations, (269) 686-3238, E-mail: nicholas.gallagher@perrigo.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.